Corentec Co

Corentec Co Capital Expenditures

The Capital Expenditures (CapEx) of Corentec Co (104540.KQ) as of Oct 30, 2026 is -3.59 B KRW. In the previous year, Capital Expenditures (CapEx) was -6.13 B KRW — a change of -41.39% (higher).

Capital Expenditures

-3.59 BKRW

YoY

-41.39%

Last updated:

Capital Expenditures (CapEx) of Corentec Co is 2025 -3.59 B KRW. Capital Expenditures (CapEx) of Corentec Co was 2024 -6.13 B KRW. It decreases by -41.39% higher compared to the previous year.

The Corentec Co Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-3.95 B KRW
Jan 1, 2019
-3.30 B KRW
Jan 1, 2020
-6.40 B KRW
Jan 1, 2021
-8.39 B KRW
Jan 1, 2022
-6.15 B KRW
Jan 1, 2023
-11.83 B KRW
Jan 1, 2024
-6.13 B KRW
Jan 1, 2025
-3.59 B KRW
The Corentec Co Capital Expenditures history
YEARCapital ExpendituresYoY
-3.59 BKRW-41.39%
-6.13 BKRW-48.15%
-11.83 BKRW+92.21%
-6.15 BKRW-26.63%
-8.39 BKRW+31.14%
-6.40 BKRW+94.02%
-3.30 BKRW-16.58%
-3.95 BKRW-71.79%
-14.01 BKRW+17.25%
-11.95 BKRW+120.49%
-5.42 BKRW+2.60%
-5.28 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Capital Expenditures (CapEx) of Corentec Co is -3.59 B KRW in 2025.

Capital Expenditures (CapEx) of Corentec Co changed from -6.13 B KRW to -3.59 B KRW, representing a -41.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Corentec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Corentec Co

All Key Metrics — Corentec Co